{"log_id": 12248238204585420, "direction": 3, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.019588, "average": 0.933256, "min": 0.419046}, "location": {"width": 38, "top": 301, "height": 1010, "left": 1983}, "words": "究中重要不良事件的发生率和严重程度均以表格的形式在上面列出另外,在上"}, {"probability": {"variance": 0.030329, "average": 0.895314, "min": 0.398877}, "location": {"width": 38, "top": 299, "height": 1012, "left": 1928}, "words": "市后的使用中或者在其他临研究甲,也有罕见的不良事件的报道,在接受杉"}, {"probability": {"variance": 0.03415, "average": 0.887585, "min": 0.450233}, "location": {"width": 38, "top": 299, "height": 1012, "left": 1871}, "words": "治疗的卵巢粉、乳腺症、非小细孢肺瘤、卡波氏肉瘤患中,不良事件的发生"}, {"probability": {"variance": 0.026424, "average": 0.87929, "min": 0.364302}, "location": {"width": 38, "top": 297, "height": 982, "left": 1814}, "words": "幸和业重程度通常相似,只是在AS相关仨卡波肉痛患者中,造血系统毒"}, {"probability": {"variance": 0.025961, "average": 0.88928, "min": 0.352849}, "location": {"width": 38, "top": 297, "height": 1014, "left": 1757}, "words": "感染《包括机会性感染)、中性粒碱小性发热的发史繁,更严重。这些"}, {"probability": {"variance": 0.025606, "average": 0.905962, "min": 0.473606}, "location": {"width": 38, "top": 297, "height": 1012, "left": 1700}, "words": "患者需要一个相对低的剂量强度,并需要支标治疗。只在卡波元离瘤老中发"}, {"probability": {"variance": 0.029747, "average": 0.906847, "min": 0.440751}, "location": {"width": 38, "top": 294, "height": 1014, "left": 1643}, "words": "生或者在这些忠者中更严重的不良事件:以及在该人群中有临床显任差别的不"}, {"probability": {"variance": 0.025668, "average": 0.899996, "min": 0.429638}, "location": {"width": 38, "top": 297, "height": 1012, "left": 1588}, "words": "良事件,以下均进行了过与有实体瘤的患名杠比,卡波肉南的患者中,肝"}, {"probability": {"variance": 0.017688, "average": 0.921014, "min": 0.548727}, "location": {"width": 38, "top": 297, "height": 614, "left": 1531}, "words": "功能试验指标升高和肾毒性的发生冷有升高趋势"}, {"probability": {"variance": 0.005929, "average": 0.941005, "min": 0.811751}, "location": {"width": 34, "top": 351, "height": 121, "left": 1476}, "words": "造血系统"}, {"probability": {"variance": 0.042046, "average": 0.8583, "min": 0.433836}, "location": {"width": 38, "top": 354, "height": 950, "left": 1414}, "words": "骨抑是禁要的剂量限制性毒性。中性拉纽地减少是最应要的造血"}, {"probability": {"variance": 0.024714, "average": 0.889046, "min": 0.363644}, "location": {"width": 41, "top": 294, "height": 1007, "left": 1357}, "words": "系统性,兵有剂量和时间依赖性:通常也可快速恢复。在卵巢癌期二线临人"}, {"probability": {"variance": 0.025088, "average": 0.912799, "min": 0.427257}, "location": {"width": 45, "top": 290, "height": 1016, "left": 1297}, "words": "光中,息者接受紫杉3小时输注,135mg2剂量组中,14%的患者中性粒细"}, {"probability": {"variance": 0.028269, "average": 0.881265, "min": 0.460381}, "location": {"width": 36, "top": 294, "height": 980, "left": 1247}, "words": "胞计低于500/m3,而175mg/m2组发生率为277(P0.05)。同样在本研究中"}, {"probability": {"variance": 0.034745, "average": 0.876969, "min": 0.359601}, "location": {"width": 36, "top": 292, "height": 1003, "left": 1190}, "words": "背续24小时注发生严的中啡粒细胞减少(心500细1mn3)的率高丁3小时"}, {"probability": {"variance": 0.031709, "average": 0.863737, "min": 0.363115}, "location": {"width": 36, "top": 292, "height": 1014, "left": 1133}, "words": "输注组:输注时问对骨髓抑的影人于剂里。重复使用并不增加中性粒细胞减"}, {"probability": {"variance": 0.025017, "average": 0.901978, "min": 0.379258}, "location": {"width": 45, "top": 290, "height": 1019, "left": 1069}, "words": "少的发生,先前按受过放射治疗的忠者发生中性粒细胞减少的率和产程度"}, {"probability": {"variance": 0, "average": 0.927319, "min": 0.927319}, "location": {"width": 47, "top": 1080, "height": 271, "left": 1016}, "words": "海"}, {"probability": {"variance": 0.0124, "average": 0.90356, "min": 0.727063}, "location": {"width": 34, "top": 292, "height": 116, "left": 1021}, "words": "没有增加"}, {"probability": {"variance": 0.032246, "average": 0.881793, "min": 0.400659}, "location": {"width": 45, "top": 349, "height": 1021, "left": 962}, "words": "在杉135mgm324小时联合顺铂治疗巢的研究以环砂胶联合"}, {"probability": {"variance": 0.031873, "average": 0.876147, "min": 0.366663}, "location": {"width": 36, "top": 290, "height": 1012, "left": 907}, "words": "顺钔为对照组,紫杉联合顺铂红Ⅳ级中性粒细胞减少中性拉细胞减少性发热"}, {"probability": {"variance": 0.05122, "average": 0.798705, "min": 0.371459}, "location": {"width": 57, "top": 290, "height": 1010, "left": 831}, "words": "的发牛率高对照,紫杉萨联合航组IⅣ级中性粒细包减能发生率为"}, {"probability": {"variance": 0.024985, "average": 0.904698, "min": 0.424086}, "location": {"width": 38, "top": 287, "height": 1014, "left": 792}, "words": "而环按联铂组的发生率为58%,而两中性粒细胞减少性发热的发生率"}, {"probability": {"variance": 0.032665, "average": 0.8917, "min": 0.389204}, "location": {"width": 38, "top": 287, "height": 1014, "left": 735}, "words": "分别为15%与4%,在杉醇顺组,1014个疗程中的35个(3%)发生热,同"}, {"probability": {"variance": 0.044737, "average": 0.844955, "min": 0.413571}, "location": {"width": 45, "top": 285, "height": 1012, "left": 674}, "words": "均伴有Ⅳ线中粒细减少的投道在针对进展明十小细胞种患者的COG"}, {"probability": {"variance": 0.023787, "average": 0.898878, "min": 0.46547}, "location": {"width": 38, "top": 285, "height": 1012, "left": 621}, "words": "研究中,紫杉醇继以铂治疗时Ⅳ级中性粒纠胞减少的发生率为74%(紫杉前"}, {"probability": {"variance": 0.023662, "average": 0.916282, "min": 0.402725}, "location": {"width": 41, "top": 287, "height": 1012, "left": 562}, "words": "35mgm2724小时后继以顺铂治疗了和65%紫杉醉250g/m724小时后继以"}, {"probability": {"variance": 0.026991, "average": 0.891832, "min": 0.417132}, "location": {"width": 38, "top": 285, "height": 760, "left": 507}, "words": "和GCSF治疗,作为对照的顺是叫乙甙组发生率为55%"}, {"probability": {"variance": 0.01841, "average": 0.941515, "min": 0.462576}, "location": {"width": 36, "top": 345, "height": 950, "left": 452}, "words": "发热是很常见的(所有治疗疗中的12%):30%的患老以及9%的疗程广"}, {"probability": {"variance": 0.035978, "average": 0.87644, "min": 0.355326}, "location": {"width": 36, "top": 287, "height": 1010, "left": 395}, "words": "均可发生感染,1%患者的感染是攻命的,包括毒症、炎、膜。卵巢癌"}, {"probability": {"variance": 0.019667, "average": 0.892445, "min": 0.469531}, "location": {"width": 41, "top": 283, "height": 1014, "left": 335}, "words": "Ⅲ二线临研究中,紫杉剂135mg/m2175mg/2持续3小时流注的患者"}], "language": 3}